| View this e-mail online |
 |
Pharma Sources Insight
June 2020 |
| Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world. Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China. Your FREE source of news and insights into China pharmaceutical industry and more! | | |
| |
| Pharma Sources Insight June 2020 focuses on the following topics: |
| COVID-19 | | -A Post-pandemic Future | | -How will the Epidemic's Identification as a PHEIC Affect China's API Export? | | -A Review of the Three Chinese Patent Medicines Affirmed by the National Administration of TCM of China to Treat COVID-19 | | -A Quick Look at the Anti-epidemic Monoclonal Antibodies that Target the Novel Coronavirus S Protein | | -Cell and Gene Therapies: Keep Calm and Carry On | | -FDA Fast Track for New Vaccine During COVID-19 Pandemic | | -Global Efforts Towards Coronavirus Vaccines：Can We Beat It? | |
| Global News | | -Technical Exploration of the Blue Ocean: Algal Polysaccharides | | -NASH: Seizing Opportunities in the Untapped Market | | -The Second ADC Approved for Marketing in China | | -Chiatai Tianqing's High-difficulty Generic Drug "Fulvestrant Injection" Approved in the US: Sales of the Original Drug was $1.028 Billion in 2018 | | -Top 50 Drugs by Sales to Sample Hospitals in China in 2019 | | -A Comparison of the Biosimilar Accessibility of China, the EU, and the U.S.: China's Biosimilars Commercialized at an Impressive Speed | |
| Industry Insight | | - Old Drugs for New Indications | |
| |
| Why Join PharmaSources.com? |
| | PharmaSources.com, as a vertical e-commerce online marketplace serving the pharmaceutical industry, is now upgraded from CPhI.CN (www.en-cphi.cn) after its 10 years' developing in the industry. Now it delivers services to over 232,000 active members across 211 countries and regions, featuring over 1,600,000 products in 30 major categories spanning the entire pharma supply chain. Our mission is to connect buyers with suppliers of the global pharmaceutical industry. | |
| Maximized Exposure | One-Stop-Shop of Pharma Supply Chain | | Company Video and 1,000 products can be released on the online store through both PC and mobile terminals. | Covering 14 niche markets including APIs, Pharma Excipients, Packaging, Lab, Natural Extracts, etc. | | One-Click-Quote | Easy Matchmaking | | Intelligent matching system help you find trustworthy suppliers. | Have a video meeting online with appointed partner at CPhI & P-MEC China 2020. | |
| |
 | Article Contribution：Julia Zhang
Tel：+86-21-33392274 E-Mail：julia.zhang@imsinoexpo.com | |
| If you don't want to receive this email any more, please click here to unsubscribe. |
No comments:
Post a Comment